at Nasdaq.com (Nov 17, 2014)
Chemtura (CHMT -10.5%) shares plunge after the maker of specialty chemicals is downgraded at Oppenheimer, which says Q4 results showed CHMT may be approaching the limits to further margin improvement without a healthier economy. Also, legacy overhead costs from its antioxidants sale will hamper margins, and 2013 capex needs are higher than expected.
From other sites
at Zacks.com (Oct 31, 2014)
at CNBC.com (Aug 26, 2014)
at MarketWatch.com (Mar 16, 2012)